Feature

Medical marijuana’s ‘Catch-22’: Federal limits on research hinder patients’ relief


 


The Trump administration, however, has resisted policy changes.

Last year, the Drug Enforcement Administration had been gearing up to allow facilities other than the University of Mississippi to grow pot for research. But after the DEA received 26 applications from other growers, Attorney General Jeff Sessions halted the initiative.

The Department of Veterans Affairs also recently announced it would not fund studies of using marijuana compounds to treat ailments such as pain.

The DEA and HHS have cited concerns about medical supervision, addiction, and a lack of “well-controlled studies proving efficacy.”

Patients, meanwhile, forge ahead.

While experts say they don’t know exactly how many older Americans rely on marijuana for medicinal purposes, the number of Americans aged 65 years and older who say they are using the drug skyrocketed 250% from 2006 to 2013.

Some patients turn to friends, patient advocacy groups, or online support groups for information.

Pages

Recommended Reading

Acupuncture for pain: 7 questions answered
MDedge Family Medicine
Severe right upper chest pain • tender right sternoclavicular joint • Dx?
MDedge Family Medicine
Bilateral thigh and knee pain • leg weakness • no history of trauma • Dx?
MDedge Family Medicine
FDA recalls kratom products for salmonella contamination
MDedge Family Medicine
MDedge Daily News: Does more marijuana mean fewer opioids?
MDedge Family Medicine
Sensitivity of vibration-based neuropathy detectors varies widely
MDedge Family Medicine
CMS finalizes measures to help combat opioid crisis
MDedge Family Medicine
Epilepsy upped risk of unnatural death
MDedge Family Medicine
Life and health are not even across the U.S.
MDedge Family Medicine
CDC: Marijuana use may spur industries to rethink current policies
MDedge Family Medicine